| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802437503028 | 243750302 | SYNAGIS INJ.SOL 100MG/ML BTx1 GLASS VIAL x 1ml | 690.48 | 700.85 | 843.44 |
For prophylaxis of respiratory diseases casued by respiratory syncytial virus.
Palivizumab binds to the fusion glycoprotein of RSV. This prevents its binding and uptake by host cellular receptors.
18-20 days (in adults)